Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hajime Asahina

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|October 9, 2003
[A case of pulmonary carcinosarcoma with abnormal uptake in bone scintigraphy]Hajime Asahina, Sigeaki Ogura, Hiroshi Yamamoto, et al.
Case Reports in Oncological Medicine|February 16, 2024
Significantly Delayed Development of Polyarthritis with Active Tenosynovitis after Possible Temporary Neutropenic Immune-Related Adverse Events Caused by Atezolizumab Treatment: A Novel Case ReportYoshitaka Saito, Yoh Takekuma, Hajime Asahina, et al.
Internal Medicine (Tokyo, Japan)|March 18, 2008
Recurrent gefitinib-induced interstitial lung diseaseMasaru Suzuki, Hajime Asahina, Jun Konishi, et al.
Case Reports in Oncology|June 29, 2023
Temporary Severe Neutropenia during Administration of Atezolizumab: A Novel Case ReportRyota Kanno, Yoshitaka Saito, Yoh Takekuma, et al.
Lung Cancer (Amsterdam, Netherlands)|July 24, 2007
Gefitinib administration in a patient with lung cancer undergoing hemodialysisNaofumi Shinagawa, Koichi Yamazaki, Hajime Asahina, et al.
Lung Cancer (Amsterdam, Netherlands)|October 19, 2006
Non-responsiveness to gefitinib in a patient with lung adenocarcinoma having rare EGFR mutations S768I and V769LHajime Asahina, Koichi Yamazaki, Ichiro Kinoshita, et al.
Clinical Lung Cancer|September 19, 2025
A Phase 2 Study of Osimertinib in Combination With Platinum-Pemetrexed in Patients With Uncommon Epidermal Growth Factor Receptor-Mutated Advanced Non-Small Cell Lung Cancer (NEJ067/OPAL2)Daisuke Morinaga, Megumi Furuta, Satoshi Morita, et al.
Clinical Lung Cancer|September 6, 2011
Retrospective analysis of third-line and fourth-line chemotherapy for advanced non-small-cell lung cancerHajime Asahina, Ikuo Sekine, Hidehito Horinouchi, et al.
Respiratory Medicine Case Reports|May 6, 2026
Leptomeningeal metastatic disease responding to carboplatin, pemetrexed, and amivantamab after progression to osimertinib in EGFR exon 21 L858R-Mutated non-small cell lung cancer: Two case reportsRyohei Kamada, Hajime Asahina, Hidenori Mizugaki, et al.
Chest|September 16, 2005
Transbronchial biopsy using endobronchial ultrasonography with a guide sheath and virtual bronchoscopic navigationHajime Asahina, Koichi Yamazaki, Yuya Onodera, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|October 9, 2003
[A case of pulmonary carcinosarcoma with abnormal uptake in bone scintigraphy]Hajime Asahina, Sigeaki Ogura, Hiroshi Yamamoto, et al.
Case Reports in Oncological Medicine|February 16, 2024
Significantly Delayed Development of Polyarthritis with Active Tenosynovitis after Possible Temporary Neutropenic Immune-Related Adverse Events Caused by Atezolizumab Treatment: A Novel Case ReportYoshitaka Saito, Yoh Takekuma, Hajime Asahina, et al.
Internal Medicine (Tokyo, Japan)|March 18, 2008
Recurrent gefitinib-induced interstitial lung diseaseMasaru Suzuki, Hajime Asahina, Jun Konishi, et al.
Case Reports in Oncology|June 29, 2023
Temporary Severe Neutropenia during Administration of Atezolizumab: A Novel Case ReportRyota Kanno, Yoshitaka Saito, Yoh Takekuma, et al.
Lung Cancer (Amsterdam, Netherlands)|July 24, 2007
Gefitinib administration in a patient with lung cancer undergoing hemodialysisNaofumi Shinagawa, Koichi Yamazaki, Hajime Asahina, et al.
Lung Cancer (Amsterdam, Netherlands)|October 19, 2006
Non-responsiveness to gefitinib in a patient with lung adenocarcinoma having rare EGFR mutations S768I and V769LHajime Asahina, Koichi Yamazaki, Ichiro Kinoshita, et al.
Clinical Lung Cancer|September 19, 2025
A Phase 2 Study of Osimertinib in Combination With Platinum-Pemetrexed in Patients With Uncommon Epidermal Growth Factor Receptor-Mutated Advanced Non-Small Cell Lung Cancer (NEJ067/OPAL2)Daisuke Morinaga, Megumi Furuta, Satoshi Morita, et al.
Clinical Lung Cancer|September 6, 2011
Retrospective analysis of third-line and fourth-line chemotherapy for advanced non-small-cell lung cancerHajime Asahina, Ikuo Sekine, Hidehito Horinouchi, et al.
Respiratory Medicine Case Reports|May 6, 2026
Leptomeningeal metastatic disease responding to carboplatin, pemetrexed, and amivantamab after progression to osimertinib in EGFR exon 21 L858R-Mutated non-small cell lung cancer: Two case reportsRyohei Kamada, Hajime Asahina, Hidenori Mizugaki, et al.
Chest|September 16, 2005
Transbronchial biopsy using endobronchial ultrasonography with a guide sheath and virtual bronchoscopic navigationHajime Asahina, Koichi Yamazaki, Yuya Onodera, et al.
Pageof 7